CXCR3A | CXCR3B | ||
---|---|---|---|
CXCL11 | CXCL10 | CXCL11 | |
cAMP inhibition | |||
N | 4 | 4 | 6 |
IC50 (nM) | 0.7 | 0.5 | N.D. |
pIC50 ± S.E.M. | −9.5 ± 0.3 | −9.4 ± 0.2 | N.D. |
Emax ± S.E.M. | 89 ± 11 | 70 ± 7 | N.D. |
β-arrestin2 | |||
N | 3 | 3 | 3 |
EC50 (nM) | 8 | 71 | 61 |
pEC50 ± S.E.M. | −8.2 ± 0.1 | −7.3 ± 0.2 | −7.2 ± 0.1 |
BRET2max ± S.E.M. | 0.11 ± 0.01 | 0.07 ± 0.01 | 0.026 ± 0.001a |
β-arrestin1 | |||
N | 3 | 3 | 3 |
EC50 (nM) | 16 | 32 | 33 |
pEC50 ± S.E.M. | −7.8 ± 0.1 | −7.5 ± 0.1 | −7.6 ± 0.2 |
BRET2max ± S.E.M. | 0.06 ± 0.01α | 0.025 ± 0.003α | 0.01 ± 0.001 |
ERK1/2 phosphorylation | |||
N | 4 | 4 | 6 |
EC50 (nM) | 2 | 3 | N.D. |
pEC50 ± S.E.M. | −8.9 ± 0.1 | −8.5 ± 0.1 | N.D. |
Emax ± S.E.M. | 368 ± 32 | 293 ± 32 | N.D. |
↵a Theoretical value, experimental curves did not reach saturation.
N.D., not detectable.